Orenda Psychiatry is disrupting the USA mental health market by leveraging telehealth platforms, concierge-style service, and a holistic, patient-centered approach primarily led by nurse practitioners. Their model addresses the access and convenience gaps faced by many patients while introducing innovations such as flexible scheduling, personalized care, advanced psychiatric interventions, and therapy integration.

Orenda faced a challenge in making ADHD diagnosis services accessible to its patients. To make this happen, Orenda needed a SAAS based ADHD assessment solution that not only meets its virtual platform, but is also suitable for both adults and children alike. This sparked the collaboration with Neurotek, the company behind MOXO.

MOXO was a clear choice for Orenda, being a cloud-native attention assessment platform designed for digital health networks and enterprises – empowering Orenda to deliver reliable, fully remote ADHD testing while managing large-scale operations through centralized data and workflow automation.
The collaboration bridges two digital-first models-Orenda’s 100% telepsychiatry service and MOXO’s remote, validated attention assessment-to make ADHD and cognitive-function evaluations truly accessible from anywhere.

The Challenge

Orenda’s mission has always been to remove barriers to psychiatric care. Yet, in traditional ADHD evaluations, clinicians rely heavily on subjective reports or in-person tests-something incompatible with a fully remote model.

The market offered almost no objective, standardized tools that could be delivered and supervised entirely online-until MOXO.

The Solution

By integrating MOXO’s cloud-based assessment directly into its digital workflow, Orenda can now provide:

  • Fully remote ADHD testing within its telepsychiatry sessions
  • Objective attention profiles that support diagnostic confidence
  • Credibility and validity checks that help clinicians identify inconsistent or falsified results
  • A seamless patient experience, requiring no hardware, installation, or clinic visit

Thousands of patients have already been assessed through this model, demonstrating the power of combining Orenda’s multi-state telehealth infrastructure with MOXO’s secure, scalable digital platform.

Executive Perspectives

“MOXO AI has transformed the way our providers diagnose and manage ADHD. With the rise in misdiagnosed or feigned cases, having objective, research-backed evidence has been invaluable. It’s convenient and easy for both clinicians and patients to use, giving our team the confidence to make accurate, data-driven decisions.”

— Kimberly Levitt, Founder and CEO Orenda Psychiatry


«The MOXO platform is meticulously engineered for clinical soundness and exceptional flexibility for large organizations. It offers effortless deployment, API integration, a robust attention profiling dataset for AI applications, and tailored in-app payment schemes,» states Dr. Yaki Dayan, Neurotek’s CEO. «We are genuinely enthusiastic about our partnership with Orenda. This represents a significant opportunity to positively impact the lives of countless individuals across the United States.»

— Dr. Yaki Dayan, CEO Neurotek


The Impact

This partnership marks a turning point in modern psychiatry-proving that objective attention assessments can be performed entirely remotely without compromising clinical quality.

Clinicians gain actionable, data-driven insights; patients gain accessibility and convenience; and Orenda strengthens its leadership in next-generation telepsychiatry.

About Orenda Psychiatry

Orenda Psychiatry is a telehealth, multi-state psychiatric practice delivering evidence-based care across a broad spectrum of mental health conditions, including ADHD, mood and anxiety disorders, trauma-related conditions, OCD, insomnia, and more.

Led by an experienced team of psychiatric nurse practitioners, Orenda blends clinical rigor with modern telehealth innovation to provide flexible, accessible, and personalized treatment.

Our secure virtual platform allows patients to receive high-quality psychiatric evaluation, medication management, and ongoing support from the comfort of home.

www.orendapsych.com

About Neurotek

Neurotek developed MOXO, a clinically validated attention and executive-function assessment for children and adults, available for both clinic and remote use.

Trusted for over a decade in 50+ countries and 1.2 million tests performed, MOXO delivers objective, data-driven insights and enterprise scalability through API integration, centralized analytics, and secure multi-site management.

www.moxo.ai